CRP and cerebrovascular disorder: As shown in Figure 2, Cox analysis showed the benefit of AZV+DXM in the subgroups of ≥65 years old (HR = 0.259, 95%CI = 0.088–0.764, p = 0.014), MODS (HR = 0.101, 95%CI = 0.046–0.221, p < 0.001), cerebrovascular disease (HR = 0.282, 95%CI = 0.10–0.794, p = 0.017), CRP ≥70 mg/L (HR = 0.312, 95%CI = 0.128–0.762, p = 0.011), and D-dimer ≥1 μg/L (HR = 0.191, 95%CI = 0.078–0.466, p < 0.001).